KalVista Pharmaceuticals, Inc. (KALV): 4 filed Feb 19, 2026

Form type

4

Filing date

Feb 19, 2026

Accession number

0001860131-26-000002

Filer

KalVista Pharmaceuticals, Inc. (CIK 1348911)